So, Capmatinib is this super-specific inhibitor that’s supposed to help treat a type of lung cancer that’s spreading like wild fire and has got these kind of fancy genetic mutations called MET exon 14 skips. And it does its magic by locking onto this thing called the MET kinase, basically making those cancer cells stop growing. You’ve got two dose options with this one: a 150 mg and a 200 mg, and they come as these easy-to-swallow film-coated pills.
They usually suggest you take 400 mg in one sitting, twice a day—no worries if you have it on an empty stomach or after chowing down. And each bottle comes with 60 of those tablets, all ready for action.
